Cargando…
Immunotherapy – The New Era of Oncology
In the field of immunotherapy, essential progress was achieved over the past years partially demonstrating long lasting therapeutic responses in different tumor entities. A better understanding of the interactions between the tumor and the immune system as well as the integration of immunotherapeuti...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
© Georg Thieme Verlag KG
2018
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6541097/ https://www.ncbi.nlm.nih.gov/pubmed/29905353 http://dx.doi.org/10.1055/s-0043-121594 |
_version_ | 1783422716941959168 |
---|---|
author | Kansy, Benjamin Lang, Stephan |
author_facet | Kansy, Benjamin Lang, Stephan |
author_sort | Kansy, Benjamin |
collection | PubMed |
description | In the field of immunotherapy, essential progress was achieved over the past years partially demonstrating long lasting therapeutic responses in different tumor entities. A better understanding of the interactions between the tumor and the immune system as well as the integration of immunotherapeutic approaches into clinical routine were the foundations for this development. The different approaches intervene on multiple levels of the immune response and directly or indirectly mount the patient‘s own immune defense against tumor cells. Immunotherapeutic approaches are represented by cytokine therapies, vaccinations, the use of oncolytic viruses and monoclonal antibody therapies as well as adoptive cell transfer strategies. |
format | Online Article Text |
id | pubmed-6541097 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | © Georg Thieme Verlag KG |
record_format | MEDLINE/PubMed |
spelling | pubmed-65410972019-05-30 Immunotherapy – The New Era of Oncology Kansy, Benjamin Lang, Stephan Laryngorhinootologie In the field of immunotherapy, essential progress was achieved over the past years partially demonstrating long lasting therapeutic responses in different tumor entities. A better understanding of the interactions between the tumor and the immune system as well as the integration of immunotherapeutic approaches into clinical routine were the foundations for this development. The different approaches intervene on multiple levels of the immune response and directly or indirectly mount the patient‘s own immune defense against tumor cells. Immunotherapeutic approaches are represented by cytokine therapies, vaccinations, the use of oncolytic viruses and monoclonal antibody therapies as well as adoptive cell transfer strategies. © Georg Thieme Verlag KG 2018-03 2018-03-22 /pmc/articles/PMC6541097/ /pubmed/29905353 http://dx.doi.org/10.1055/s-0043-121594 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited. |
spellingShingle | Kansy, Benjamin Lang, Stephan Immunotherapy – The New Era of Oncology |
title | Immunotherapy – The New Era of Oncology |
title_full | Immunotherapy – The New Era of Oncology |
title_fullStr | Immunotherapy – The New Era of Oncology |
title_full_unstemmed | Immunotherapy – The New Era of Oncology |
title_short | Immunotherapy – The New Era of Oncology |
title_sort | immunotherapy – the new era of oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6541097/ https://www.ncbi.nlm.nih.gov/pubmed/29905353 http://dx.doi.org/10.1055/s-0043-121594 |
work_keys_str_mv | AT kansybenjamin immunotherapytheneweraofoncology AT langstephan immunotherapytheneweraofoncology |